LUNEXIS Trademark Information

On Wednesday, December 2, 2020, a U.S. federal trademark registration was filed for LUNEXIS. The USPTO has given the LUNEXIS trademark serial number of 90354592. The current federal status of this trademark filing is OPPOSITION PENDING. The correspondent listed for LUNEXIS is DEVON E. WHITE of ********,********, ***** **** . The LUNEXIS trademark is filed in the category of Computer & Software Services & Scientific Services . The description provided to the USPTO for LUNEXIS is Software as a Service (SaaS) services featuring software for submitting, transmitting, accessing, editing, managing and sharing data digital content, namely, documents, audio, video and handwritten notes, related to patient questionnaires, patient recruiting, patient consents, patient enrollment, and patient monitoring for digital monitoring of clinical trials; Providing temporary use of a non-downloadable web application for submitting, transmitting, accessing, editing, managing and sharing data and digital content, namely, documents, audio, video and handwritten notes, related to patient questionnaires, patient recruiting, patient consents, patient enrollment, and patient monitoring for digital monitoring of clinical trials; Providing temporary use of a web-based software application for submitting, transmitting, accessing, editing, managing and sharing data and digital content, namely, documents, audio, video and handwritten notes, related to patient questionnaires, patient recruiting, patient consents, patient enrollment, and patient monitoring for digital monitoring of clinical trials; Providing clinical tools in the nature of a non-downloadable Software as a Service (SaaS) computer application that combines multiple clinical assessments, defines the logic between them, and incorporates sophisticated data validations and workflow execution dynamics to simplify the complexity of administering these questionnaires to patients; Providing temporary use of a web-based software application that allows medical professionals and medical patients to access medical information from remote locations via electronic devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of digital monitoring of clinical trials.